Pediatric hormonal disturbances after hematopoietic stem cell transplantation

References

• Chemaitilly W, Sklar CA. Endocrine complications of hematopoietic stem cell transplantation. Endocrinol. Metab. Clin. North Am. 36(4), 983–998; ix (2007).
   PubMed Web of Science ®Google Scholar
• Frangoul H, Najjar J, Simmons J, Domm J. Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation. Semin. Hematol. 49(1), 94–103 (2012).
   Google Scholar
• Rutter MM, Rose SR. Long-term endocrine sequelae of childhood cancer. Curr. Opin. Pediatr. 19(4), 480–487 (2007).
   PubMed Web of Science ®Google Scholar
• Linsenmeier C, Thoennessen D, Negretti L et al. Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation. Strahlenther. Onkol. 186(11), 614–620 (2010).
   Google Scholar
• Sanders JE. Growth and development after bone marrow transplantation. In: Bone Marrow Transplantation. Forman JS, Blume KG, Thomas ED (Eds). Blackwell Scientific Publications, MA, USA, 527–537 (1994)
   Google Scholar
• Ho J, Lewis V, Guilcher GM, Stephure DK, Pacaud D. Endocrine complications following pediatric bone marrow transplantation. J. Pediatr. Endocrinol. Metab. 24(5–6), 327–332 (2011).
   Google Scholar
• Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr. Suppl. 411, 57–61; discussion 62 (1995).
   PubMedGoogle Scholar
• Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356(9234), 993–997 (2000).
   PubMed Web of Science ®Google Scholar
• Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 105(3), 1348–1354 (2005).
   PubMed Web of Science ®Google Scholar
• Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7), 3045–3052 (1996).
   PubMed Web of Science ®Google Scholar
• Sanders JE, Hoffmeister PA, Woolfrey AE et al. Thyroid function following hematopoietic cell transplantation in children: 30 years’ experience. Blood 113(2), 306–308 (2009).
   PubMed Web of Science ®Google Scholar
• Lee PA, Hook CP. Puberty and its disorders. In: Pediatric Endocrinology (Volume 2, 5th Edition). Lifshitz F (Ed.). Informe Healthcare, NY, USA, 273–304 (2007).
   Google Scholar
• Ogilvy-Stuart AL, Clark DJ, Wallace WH et al. Endocrine deficit after fractionated total body irradiation. Arch. Dis. Child. 67(9), 1107–1110 (1992).
   PubMed Web of Science ®Google Scholar
• Bailey HK, Kappy MS, Giller RH, Gralla J. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr. Blood Cancer 51(3),405–409 (2008).
   Google Scholar
• Toogood AA. Endocrine consequences of brain irradiation. Growth Horm. IGF Res. 14(Suppl. A), S118–S124 (2004).
   Google Scholar
• Laporte S, Couto-Silva AC, Trabado S et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr. 11, 20 (2011).
   Google Scholar
• Loren AW, Chow E, Jacobsohn DA et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol. Blood Marrow Transplant. 17(2), 157–166 (2011).
   PubMed Web of Science ®Google Scholar
• Salooja N, Szydlo RM, Socie G et al.; Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358(9278), 271–276 (2001).
   PubMed Web of Science ®Google Scholar
• Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet. Gynecol. 116(5), 1171–1183 (2010).
   PubMed Web of Science ®Google Scholar
• Oktem O, Urman B. Options of fertility preservation in female cancer patients. Obstet. Gynecol. Surv. 65(8), 531–542 (2010).
   Google Scholar
• Georgescu ES, Goldberg JM, du Plessis SS, Agarwal A. Present and future fertility preservation strategies for female cancer patients. Obstet. Gynecol. Surv. 63(11), 725–732 (2008).
   PubMed Web of Science ®Google Scholar
• Beck-Fruchter R, Weiss A, Shalev E. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum. Reprod. Update 14(6), 553–561 (2008).
   PubMed Web of Science ®Google Scholar
• Green DM, Sklar CA, Boice JD Jr et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J. Clin. Oncol. 27(14), 2374–2381 (2009).
   PubMed Web of Science ®Google Scholar
• Nitzschke M, Raddatz J, Bohlmann MK, Stute P, Strowitzki T, von Wolff M. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin’s lymphoma patients. Arch. Gynecol. Obstet. 282(1), 83–88 (2010).
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z. Fertility preservation and GnRH-a for chemotherapy: debate. Arch. Gynecol. Obstet. 282(5), 585–586 (2010).
   Google Scholar
• Remérand G, Merlin E, Froissart R et al. Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation. J. Inherit. Metab. Dis. doi:10.1038/sj.bmt.1705718 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Andersson AM, Petersen JH, Jørgensen N, Jensen TK, Skakkebaek NE. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J. Clin. Endocrinol. Metab. 89(6), 2873–2879 (2004).
   PubMed Web of Science ®Google Scholar
• Knauff EA, Eijkemans MJ, Lambalk CB et al.; Dutch Premature Ovarian Failure Consortium. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J. Clin. Endocrinol. Metab. 94(3), 786–792 (2009).
   PubMed Web of Science ®Google Scholar
• Oktay K, Sönmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12(9), 1055–1066 (2007).
   PubMed Web of Science ®Google Scholar
• Oehninger S. Strategies for fertility preservation in female and male cancer survivors. J. Soc. Gynecol. Investig. 12(4), 222–231 (2005).
   Google Scholar
• Meseguer M, Garrido N, Remohí J, Pellicer A, Gil-Salom M. Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) in hypogonadotropic hypogonadism with persistent azoospermia after hormonal therapy. J. Assist. Reprod. Genet. 21(3), 91–94 (2004).
   Google Scholar
• Kim G, Caprio S. Diabetes and insulin resistance in pediatric obesity. Pediatr. Clin. North Am. 58(6), 1355–1361, ix (2011).
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Adams-Huet B, Victor RG et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. J. Clin. Oncol. 27(22),3698–3704 (2009).
   PubMed Web of Science ®Google Scholar
• Tonorezos ES, Vega GL, Sklar CA et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr. Blood Cancer 58(1), 31–36 (2012).
   PubMed Web of Science ®Google Scholar
• Meacham LR, Sklar CA, Li S et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch. Intern. Med. 169(15), 1381–1388 (2009).
   PubMed Web of Science ®Google Scholar
• Chow EJ, Simmons JH, Roth CL et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol. Blood Marrow Transplant. 16(12), 1674–1681 (2010).
   PubMed Web of Science ®Google Scholar
• Baker KS, Ness KK, Steinberger J et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109(4), 1765–1772 (2007).
   PubMed Web of Science ®Google Scholar
• Paris C, Yates L, Lama P, Zepeda AJ, Gutiérrez D, Palma J. Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatr. Blood Cancer 59(2), 306–310 (2012).
   Google Scholar
• Oudin C, Simeoni MC, Sirvent N et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 117(17), 4442–4448 (2011).
   PubMed Web of Science ®Google Scholar
• Leroith D. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with Type 2 diabetes. Am. J. Med. Sci. 343(1), 13–16 (2012).
   Google Scholar
• Neville KA, Cohn RJ, Steinbeck KS, Johnston K, Walker JL. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J. Clin. Endocrinol. Metab. 91(11), 4401–4407 (2006).
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Yasuda Y, Tomita Y et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J. Clin. Endocrinol. Metab. 89(12), 5981–5986 (2004).
   PubMed Web of Science ®Google Scholar
• Katsanis E, Shapiro RS, Robison LL et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant. 5(5), 335–340 (1990).
   PubMed Web of Science ®Google Scholar
• Al-Fiar FZ, Colwill R, Lipton JH, Fyles G, Spaner D, Messner H. Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants. Bone Marrow Transplant. 19(10), 1019–1022 (1997).
   Google Scholar
• Ricardi U, Filippi AR, Biasin E et al. Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies. Strahlenther. Onkol. 185(Suppl. 2), 17–20 (2009).
   Google Scholar
• Berger C, Le-Gallo B, Donadieu J et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant. 35(10), 991–995 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen A, Rovelli A, van Lint MT et al. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant. 28(12), 1125–1128 (2001).
   Google Scholar
• Nandagopal R, Laverdière C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Horm. Res. 69(2), 65–74 (2008).
   PubMedGoogle Scholar
• Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clin. Endocrinol. (Oxf.) 67(4), 589–597 (2007).
   Google Scholar
• Frisk P, Arvidson J, Gustafsson J, Lönnerholm G. Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant. 33(2), 205–210 (2004).
   Google Scholar
• Cohen A, Rovelli A, Van-Lint MT et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch. Dis. Child. 74(5), 437–440 (1996).
   Google Scholar
• Brownstein CM, Mertens AC, Mitby PA et al. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J. Clin. Endocrinol. Metab. 89(9), 4422–4427 (2004).
   Google Scholar
• Lerner SE, Huang GJ, McMahon D, Sklar CA, Oberfield SE. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes. J. Clin. Endocrinol. Metab. 89(12), 6100–6104 (2004).
   Google Scholar
• Giorgiani G, Bozzola M, Locatelli F et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86(2), 825–831 (1995).
   PubMed Web of Science ®Google Scholar
• Holm K, Nysom K, Rasmussen MH et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant. 18(1), 163–170 (1996).
   PubMedGoogle Scholar
• Brauner R, Adan L, Souberbielle JC et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J. Pediatr. 130(5), 785–792 (1997).
   PubMed Web of Science ®Google Scholar
• Ergun-Longmire B, Mertens AC, Mitby P et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J. Clin. Endocrinol. Metab. 91(9), 3494–3498 (2006).
   PubMed Web of Science ®Google Scholar
• Sklar CA, Mertens AC, Mitby P et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J. Clin. Endocrinol. Metab. 87(7), 3136–3141 (2002).
   PubMed Web of Science ®Google Scholar
• Taitz J, Cohn RJ, White L, Russell SJ, Vowels MR. Osteochondroma after total body irradiation: an age-related complication. Pediatr. Blood Cancer 42(3), 225–229 (2004).
   PubMed Web of Science ®Google Scholar
• Tauchmanovà L, Selleri C, Rosa GD et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 95(5), 1076–1084 (2002).
   PubMed Web of Science ®Google Scholar
• Frisk P, Gustafsson J, Arvidson J. Normal spontaneous cortisol secretion in children after autologous bone marrow transplantation. Acta Paediatr. 94(10), 1411–1415 (2005).
   Google Scholar
• Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant. 33(10), 1049–1056 (2004).
   Google Scholar
• Savas-Erdeve S, Berberoglu M, Siklar Z et al. Primary adrenal insufficiency in a child afterbusulfan and cyclophosphamide-based conditioning for hematopoietic stem cell transplantation. J. Pediatr. Endocrinol. Metab. 24(9–10), 853–855 (2011).
   Google Scholar